Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

Stifel lifts Arvinas shares PT on ARV-766 sales forecast update

Published 11/04/2024, 15:14

On Thursday, Stifel maintained a Buy rating on Arvinas Inc. (NASDAQ:ARVN) and increased the price target to $72 from $70. The adjustment reflects a new financial strategy regarding ARV-766, a product in Arvinas' pipeline. Stifel now anticipates that Arvinas will receive royalties from this product instead of direct sales revenue.

The firm acknowledged the potential for higher sales estimates and the inclusion of milestone payments, especially given the possibility of an expanded and accelerated development plan by Novartis (SIX:NOVN) for ARV-766. However, Stifel chose to retain a cautious outlook until more information becomes available.

Arvinas has been actively investing in research and development (R&D) for its AR program, with expenditures of $80 million in 2023 and $58 million the previous year. In light of these figures, Stifel has moderated its expense forecasts for Arvinas.

The update on the price target and sales forecast comes as analysts continually evaluate the potential of Arvinas' partnership with Novartis and its implications for the company's financial performance. The current valuation reflects Stifel's confidence in the company's prospects, tempered by a prudent financial approach.

InvestingPro Insights

As Arvinas Inc. (NASDAQ:ARVN) continues to focus on its R&D efforts, particularly for ARV-766, it's crucial to consider the company's financial health and market performance. According to InvestingPro data, Arvinas holds a market cap of approximately $2.59 billion, with a notably high P/E ratio of -5.49, reflecting its current lack of profitability. This is further substantiated by the company's negative revenue growth over the last twelve months as of Q4 2023, sitting at -40.26%, and a significant quarterly revenue decline of -214.02%.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

On the positive side, InvestingPro Tips indicate that Arvinas holds more cash than debt on its balance sheet, providing financial stability. Additionally, the stock's recent performance suggests it is in oversold territory according to the Relative Strength Index (RSI), which could signal a potential buying opportunity for investors. It's also worth noting that six analysts have revised their earnings upwards for the upcoming period, hinting at a more optimistic future outlook.

Investors considering Arvinas as an investment option can find further insights and additional tips on InvestingPro, including 10 more detailed InvestingPro Tips to help inform their decisions. For those looking to delve deeper into the company's analytics, use coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription at https://www.investing.com/pro/ARVN.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.